Detalhe da pesquisa
1.
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.
Cell
; 167(2): 405-418.e13, 2016 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27693350
2.
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.
Blood
; 141(20): 2493-2507, 2023 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302166
3.
Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.
Cell
; 142(5): 699-713, 2010 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20813259
4.
A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.
Blood
; 139(6): 889-893, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662378
5.
A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
Nature
; 560(7718): 387-391, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29925955
6.
Characterization of DLBCL with a PMBL gene expression signature.
Blood
; 138(2): 136-148, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33684939
7.
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC.
Blood
; 137(16): 2196-2208, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33120427
8.
HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species.
Nat Immunol
; 11(3): 265-72, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20139987
9.
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.
Blood
; 136(5): 572-584, 2020 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32160292
10.
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 378(15): 1396-1407, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29641966
11.
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.
Blood
; 134(10): 802-813, 2019 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292115
12.
The whole-genome landscape of Burkitt lymphoma subtypes.
Blood
; 134(19): 1598-1607, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558468
13.
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Blood
; 133(15): 1664-1676, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782609
14.
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.
Haematologica
; 106(10): 2682-2693, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951889
15.
Single Cell Phenotypic Profiling of 27 DLBCL Cases Reveals Marked Intertumoral and Intratumoral Heterogeneity.
Cytometry A
; 97(6): 620-629, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31637838
16.
High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.
Blood
; 131(18): 2060-2064, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29475959
17.
Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles.
Blood
; 132(16): 1695-1702, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126979
18.
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.
Blood
; 131(2): 226-235, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29122756
19.
Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.
Blood
; 132(22): 2401-2405, 2018 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30257882
20.
Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation.
Blood
; 131(18): 2036-2046, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29467182